CN1762948A - 一种聚桂醇生产的处方及其制备工艺方法 - Google Patents
一种聚桂醇生产的处方及其制备工艺方法 Download PDFInfo
- Publication number
- CN1762948A CN1762948A CN 200510096038 CN200510096038A CN1762948A CN 1762948 A CN1762948 A CN 1762948A CN 200510096038 CN200510096038 CN 200510096038 CN 200510096038 A CN200510096038 A CN 200510096038A CN 1762948 A CN1762948 A CN 1762948A
- Authority
- CN
- China
- Prior art keywords
- polidocanol
- oxyethane
- prescription
- preparation technology
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 54
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 45
- 229920001363 Polidocanol Polymers 0.000 claims description 42
- 229960002226 polidocanol Drugs 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 claims description 40
- 239000000047 product Substances 0.000 claims description 34
- 229940079593 drug Drugs 0.000 claims description 22
- 238000005516 engineering process Methods 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 18
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 16
- 239000012043 crude product Substances 0.000 claims description 14
- 239000000523 sample Substances 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 12
- 238000010792 warming Methods 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 238000013019 agitation Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 8
- 239000002674 ointment Substances 0.000 claims description 7
- 238000005070 sampling Methods 0.000 claims description 7
- 239000000376 reactant Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 5
- 239000011229 interlayer Substances 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 239000003351 stiffener Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000004043 dyeing Methods 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 238000007639 printing Methods 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 abstract description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 4
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 4
- 239000003054 catalyst Substances 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 238000006116 polymerization reaction Methods 0.000 abstract description 3
- 229920002884 Laureth 4 Polymers 0.000 abstract description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000013558 reference substance Substances 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 229940090044 injection Drugs 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000003556 assay Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 4
- RXNBDWQDJKUHNH-UHFFFAOYSA-L azane;cobalt(2+);dithiocyanate Chemical compound N.[Co+2].[S-]C#N.[S-]C#N RXNBDWQDJKUHNH-UHFFFAOYSA-L 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- INDBQWVYFLTCFF-UHFFFAOYSA-L cobalt(2+);dithiocyanate Chemical compound [Co+2].[S-]C#N.[S-]C#N INDBQWVYFLTCFF-UHFFFAOYSA-L 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 4
- 229940116357 potassium thiocyanate Drugs 0.000 description 4
- 238000002798 spectrophotometry method Methods 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 208000000624 Esophageal and Gastric Varices Diseases 0.000 description 2
- KGWDUNBJIMUFAP-KVVVOXFISA-N Ethanolamine Oleate Chemical compound NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O KGWDUNBJIMUFAP-KVVVOXFISA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- GRIXGZQULWMCLU-UHFFFAOYSA-L disodium;7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].C12OCC(CSC=3N(N=NN=3)C)=C(C([O-])=O)N2C(=O)C1(OC)NC(=O)C(C([O-])=O)C1=CC=C(O)C=C1 GRIXGZQULWMCLU-UHFFFAOYSA-L 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- -1 Polyoxyethylene Lauryl ether Polymers 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 208000024170 esophageal varices Diseases 0.000 description 1
- 201000010120 esophageal varix Diseases 0.000 description 1
- 229940098775 ethamolin Drugs 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 229940025913 polidocanol injection Drugs 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960005491 sodium morrhuate Drugs 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
国外 | 本发明 | 备注 | |
催化剂 | Mg2+Ba2+Al3+Ni2+Sr3+Fe3+Mn2+Zn2+Na+等氧化物及盐类 | 固体NaoH | |
过滤工序 | 有 | 无 | |
中和试剂 | H3PO4(磷酸) | HAC(醋酸) |
项目 | 质量指标 |
[性状] | 本品为无色至白色的粘稠液体或白色软膏状物;在10℃以下呈白色蜡状软物;有特异臭,味微苦,略有刺激性。 |
[鉴别] | |
化学反应 | 应呈正反应[本品0.5g+H2O10ml+硫氰酸钴铵溶液5ml+氯仿5ml摇匀,放置,氯仿层显兰色] |
红外图谱 | 本品在波长1347cm-1,1246cm-1附近有吸收峰。 |
[检查] | |
酸度 | 应呈正反应[本品10g+中性乙醇50ml→水浴加热近沸,并时时振摇,放冷十氢氧化物溶液(0.1mol/L5.3ml及酚酞试液5滴,溶液呈红色] |
水分 | 不得过1.0% |
不饱和物 | 应符合国家SFDA(试行)药品标准规定 |
炽灼残渣 | 不得过0.1% |
平均分子量 | 应为560~630 |
[含量测定] | 含聚桂醇C12H25(OCH2CH2)nOH不得少于98.0% |
[类别] | 硬化剂 |
[贮藏] | 密闭,在凉暗处保存 |
[制剂] | 供注射液用 |
[附注] | 硫氰酸钴铵试液的配制;称取硝酸钴[CO(NO3)·6H2O]30g,氯化铵143g与硫氰化钾256g,加水溶解使成1000ml;另法为硝酸钴30g,硫氰酸铵与氯化钾各200g,加水溶解使成1000ml,即得。 |
项目 | 质量指标 |
[性状] | 本品为无色至白色的粘稠液体或白色软膏状物;在10℃以下呈白色蜡状软物;有特异臭,味微苦,略有刺激性。 |
[鉴别] | |
化学反应 | 应呈正反应[本品0.5g+H2O10ml+硫氰酸钴铵溶液5ml+氯仿5ml摇匀,放置,氯仿层显兰色] |
红外图谱 | 本品在波长1347cm-1,1246cm-1附近有吸收峰。 |
[检查] | |
酸度 | 应呈正反应[本品10g+中性乙醇50ml→水浴加热近沸,并时时振摇,放冷十氢氧化物溶液(0.1mol/L5.3ml及酚酞试液5滴,溶液呈红色] |
水分 | 不得过1.0% |
不饱和物 | 应符合国家SFDA(试行)药品标准规定 |
炽灼残渣 | 不得过0.1% |
平均分子量 | 应为560~630 |
[含量测定] | 含聚桂醇C12H25(OCH2CH2)nOH不得少于98.0% |
[类别] | 硬化剂 |
[贮藏] | 密闭,在凉暗处保存 |
[制剂] | 供注射液用 |
[附注] | 硫氰酸钴铵试液的配制;称取硝酸钴[CO(NO3)·6H2O]30g,氯化铵143g与硫氰化钾256g,加水溶解使成1000ml;另法为硝酸钴30g,硫氰酸铵与氯化钾各200g,加水溶解使成1000ml,即得。 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100960384A CN100335453C (zh) | 2005-09-16 | 2005-09-16 | 一种聚桂醇的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100960384A CN100335453C (zh) | 2005-09-16 | 2005-09-16 | 一种聚桂醇的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1762948A true CN1762948A (zh) | 2006-04-26 |
CN100335453C CN100335453C (zh) | 2007-09-05 |
Family
ID=36747305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100960384A Active CN100335453C (zh) | 2005-09-16 | 2005-09-16 | 一种聚桂醇的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100335453C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041860A (zh) * | 2013-01-24 | 2013-04-17 | 凤台精兴生物科技有限公司 | 用于在壬基酚聚氧乙烯醚合成反应中的碱性复配催化剂 |
CN103044674A (zh) * | 2012-12-14 | 2013-04-17 | 江苏省海安石油化工厂 | 匀染剂的制备方法 |
CN103922901A (zh) * | 2014-04-18 | 2014-07-16 | 南京正大天晴制药有限公司 | 聚桂醇的精制方法 |
CN104649863A (zh) * | 2013-11-15 | 2015-05-27 | 北京万诚伟业医药科技有限公司 | 一种月桂醇纯化方法以及一种聚桂醇制备方法 |
CN104666283A (zh) * | 2010-06-10 | 2015-06-03 | 克施乐化学工厂两合公司 | 制备醇乙氧基化物的方法及产品 |
CN110015950A (zh) * | 2010-06-10 | 2019-07-16 | 克施乐化学工厂两合公司 | 制备醇乙氧基化物的方法及产品 |
CN113200821A (zh) * | 2021-04-29 | 2021-08-03 | 南京威尔生物科技有限公司 | 一种月桂醇的提纯方法及聚多卡醇的合成方法 |
-
2005
- 2005-09-16 CN CNB2005100960384A patent/CN100335453C/zh active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104666283A (zh) * | 2010-06-10 | 2015-06-03 | 克施乐化学工厂两合公司 | 制备醇乙氧基化物的方法及产品 |
CN104666283B (zh) * | 2010-06-10 | 2019-01-08 | 克施乐化学工厂两合公司 | 制备醇乙氧基化物的方法及产品 |
CN110015950A (zh) * | 2010-06-10 | 2019-07-16 | 克施乐化学工厂两合公司 | 制备醇乙氧基化物的方法及产品 |
CN103044674A (zh) * | 2012-12-14 | 2013-04-17 | 江苏省海安石油化工厂 | 匀染剂的制备方法 |
CN103041860A (zh) * | 2013-01-24 | 2013-04-17 | 凤台精兴生物科技有限公司 | 用于在壬基酚聚氧乙烯醚合成反应中的碱性复配催化剂 |
CN103041860B (zh) * | 2013-01-24 | 2015-03-25 | 凤台精兴生物科技有限公司 | 用于在壬基酚聚氧乙烯醚合成反应中的碱性复配催化剂 |
CN104649863A (zh) * | 2013-11-15 | 2015-05-27 | 北京万诚伟业医药科技有限公司 | 一种月桂醇纯化方法以及一种聚桂醇制备方法 |
CN104649863B (zh) * | 2013-11-15 | 2017-06-06 | 北京万诚伟业医药科技有限公司 | 一种月桂醇纯化方法以及一种聚桂醇制备方法 |
CN103922901A (zh) * | 2014-04-18 | 2014-07-16 | 南京正大天晴制药有限公司 | 聚桂醇的精制方法 |
CN103922901B (zh) * | 2014-04-18 | 2015-08-19 | 南京正大天晴制药有限公司 | 聚桂醇的精制方法 |
CN113200821A (zh) * | 2021-04-29 | 2021-08-03 | 南京威尔生物科技有限公司 | 一种月桂醇的提纯方法及聚多卡醇的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100335453C (zh) | 2007-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100335453C (zh) | 一种聚桂醇的制备方法 | |
CN110283583B (zh) | γ-谷氨酰转肽酶响应型分子探针及其应用 | |
CN113322065B (zh) | 一种荧光碳量子点及其制备方法和在制备抗肿瘤药物增敏剂中的用途 | |
CN1751032A (zh) | {6,7-双(2-甲氧基-乙氧基)-喹唑啉-4-基}-(3e)的多晶型 | |
CN101230390A (zh) | 一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法 | |
CN1424031A (zh) | 含有银杏内酯的制剂及其制备工艺 | |
CN109504363A (zh) | 一种近红外二区成像造影剂的制备方法和用途 | |
CN1775215A (zh) | 盐酸阿扎司琼葡萄糖注射液制剂、制备方法及其质量控制技术 | |
CN1958568A (zh) | 一类预防或治疗幽门螺杆菌感染化合物、其制法和用途 | |
CN1037266C (zh) | 喹啉衍生物的富马酸盐及其制法和其药物组合物 | |
CN105602276B (zh) | 可聚合近红外荧光染料单体及其制备方法、用途 | |
CN114685348B (zh) | 一种具有aie性质的近红外花菁类光敏剂及其制备方法与应用 | |
CN102964335B (zh) | 一种埃索美拉唑钠化合物及其制备方法和用途 | |
CN101054383A (zh) | 溴代双氢青蒿素及其制备方法 | |
CN114853735A (zh) | 靶向泛素化降解trk的化合物及其制备方法、组合物和用途 | |
CN100354247C (zh) | 杯芳烃类贫铀促排剂、其制备方法和用途 | |
CN108553649B (zh) | 一种新颖的管道结构的索拉非尼-γ-环糊精包合物及制备方法及应用 | |
CN1579377A (zh) | 姜黄素在制备治疗肺病的药物中的用途 | |
CN103127520B (zh) | 聚乙二醇与坦索罗辛的结合物及其药物组合物 | |
CN1231216C (zh) | 门冬氨酸洛美沙星粉剂及其制备方法 | |
CN1326449A (zh) | 5-[{6-(2-氟苄基)氧基-2-萘基}甲基]-2,4-噻唑烷二酮的晶体 | |
CN1302815C (zh) | 甲苯胺蓝o药物及其在异常组织的体内染色和化疗中的用途 | |
CN1785985A (zh) | 一种去甲斑蝥酸钠药物化合物及其制备方法与应用 | |
CN117903244A (zh) | 一种小分子荧光探针及其制备方法和应用 | |
CN1224386C (zh) | 一种用于治疗癌症的夫马吉欣注射剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20111122 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2011990000445 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20121220 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2011990000445 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20121220 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2012990000821 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20131209 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2012990000821 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20131209 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2013990000949 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141216 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2013990000949 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20141217 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2014990001085 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20151228 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2014990001085 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20151229 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2015990001188 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170112 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2015990001188 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20170112 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2017990000029 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171025 Granted publication date: 20070905 Pledgee: Bank of Xi'an Limited by Share Ltd. South Second Ring branch Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2017990000029 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20171027 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2017610000131 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191114 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: 2017610000131 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Polycinnamic alcohol production formula and its preparation process Effective date of registration: 20191114 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: Y2019980000604 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211201 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: Y2019980000604 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of polylauryl alcohol Effective date of registration: 20211206 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: Y2021610000392 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231211 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: Y2021610000392 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Preparation Method of Polycinnamyl Alcohol Effective date of registration: 20231215 Granted publication date: 20070905 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI TIANYU PHARMACEUTICAL Co.,Ltd. Registration number: Y2023610000767 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |